Receptor-mediated and enzyme-dependent targeting of cytotoxic anticancer drugs
- 1 August 1999
- journal article
- review article
- Published by Elsevier in Pharmacology & Therapeutics
- Vol. 83 (2) , 67-123
- https://doi.org/10.1016/s0163-7258(99)00018-2
Abstract
No abstract availableKeywords
This publication has 463 references indexed in Scilit:
- Pharmacologic Modification of Tumor Blood Flow and Interstitial Fluid Pressure in a Human Tumor Xenograft: Network Analysis and Mechanistic InterpretationMicrovascular Research, 1995
- Tissue localization of methotrexate-monoclonal-IgM immunoconjugates: Anti-SSEA-1 and MOPC 104E in mouse teratocarcinomas and normal tissuesCancer Immunology, Immunotherapy, 1992
- Doxorubicin: monoclonal antibody conjugate for therapy of human cervical carcinomaInternational Journal of Cancer, 1992
- Capture of recombinant ricin A chain by a bispecific anti-RTA: anti-CEA monoclonal antibody pre-targeted to a human gastric carcinoma xenograft in nude miceZeitschrift für Krebsforschung und Klinische Onkologie, 1992
- Adriamycin(hydrazone)-antibody conjugates require internalization and intracellular acid hydrolysis for antitumor activityCancer Immunology, Immunotherapy, 1991
- Monoclonal antibody L6-daunomycin conjugates constructed to release free drug at the lower pH of tumor tissueCancer Immunology, Immunotherapy, 1991
- Antibody-penicillin-V-amidase conjugates kill antigen-positive tumor cells when combined with doxorubicin phenoxyacetamideCancer Immunology, Immunotherapy, 1990
- Suppression of well-established tumour xenografts by a hybrid-hybrid monoclonal antibody and vinblastineCancer Immunology, Immunotherapy, 1990
- Effective drug-antibody targeting using a novel monoclonal antibody against the proliferative compartment of mammalian squamous carcinomasCancer Immunology, Immunotherapy, 1990
- Preparation of four daunomycin‐monoclonal antibody 79IT/36 conjugates with anti‐tumour activityInternational Journal of Cancer, 1984